Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. (abre uma nova janela)

Abdel-Aleem H, Alhusaini TK, Abdel-Aleem MA, Menoufy M, Gülmezoglu AM.

Fonte‎: J Matern Fetal Neonatal Med 2013;26(17):1705-9.

Indexado‎: PubMed 23574458

https://www.ncbi.nlm.nih.gov/pubmed/23574458 (abre uma nova janela)

Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. (abre uma nova janela)

Gayet-Ageron A, Prieto-Merino D, Ker K, Shakur H, Ageron FX, Roberts I; Antifibrinolytic Trials Collaboration

Fonte‎: Lancet 2018;391(10116):125-32.

Indexado‎: PubMed 29126600

DOI‎: 10.1016/S0140-6736(17)32455-8

https://www.ncbi.nlm.nih.gov/pubmed/29126600 (abre uma nova janela)

Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study. (abre uma nova janela)

Gungorduk K, Asıcıoğlu O, Yıldırım G, Ark C, Tekirdağ Aİ, Besımoglu B.

Fonte‎: Am J Perinatol 2013;30(5):407-13.

Indexado‎: PubMed 23023559

DOI‎: 10.1055/s-0032-1326986

https://www.ncbi.nlm.nih.gov/pubmed/23023559 (abre uma nova janela)

Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. (abre uma nova janela)

Gungorduk K, Yıldırım G, Asıcıoğlu O, Gungorduk OC, Sudolmus S, Ark C.

Fonte‎: Am J Perinatol 2011;28(3):233-40.

Indexado‎: PubMed 20979013

https://www.ncbi.nlm.nih.gov/pubmed/20979013 (abre uma nova janela)

Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. (abre uma nova janela)

Shakur S, Roberts I, Fawole B, Chaudhri R, El-Sheikh M, et al.; WOMAN Trial Collaborators

Fonte‎: Lancet 2017;389(10084):2105-16.

Indexado‎: PubMed 28456509

DOI‎: 10.1016/S0140-6736(17)30638-4

https://www.ncbi.nlm.nih.gov/pubmed/28456509 (abre uma nova janela)

Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials. (abre uma nova janela)

Simonazzi G, Bisulli M, Saccone G, Moro E, Marshall A, Berghella V.

Fonte‎: Acta Obstet Gynecol Scand 2016;95(1):28-37.

Indexado‎: PubMed 26698831

DOI‎: 10.1111/aogs.12798

https://www.ncbi.nlm.nih.gov/pubmed/26698831 (abre uma nova janela)

Randomized controlled trial of tranexamic acid among parturients at increased risk for postpartum hemorrhage undergoing cesarean delivery. (abre uma nova janela)

Sujata N, Tobin R, Kaur R, Aneja A, Khanna M, Hanjoora VM.

Fonte‎: Int J Gynaecol Obstet 2016;133(3):312-5.

Indexado‎: PubMed 26952346

DOI‎: 10.1016/j.ijgo.2015.09.032

https://www.ncbi.nlm.nih.gov/pubmed/26952346 (abre uma nova janela)

Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004. (abre uma nova janela)

Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, Ahonen J, Bremme K, Bødker B, Magnúsdóttir EM, Salvesen K, Prendiville W, Truesdale A, Clemens F, Piercy D, Gyte G.

Fonte‎: Obstet Gynecol 2007;110(6):1270-8.

Indexado‎: PubMed 18055720

DOI‎: 10.1097/01.AOG.0000288515.48066.99

https://www.ncbi.nlm.nih.gov/pubmed/18055720 (abre uma nova janela)

The use of recombinant activated FVII in postpartum hemorrhage. (abre uma nova janela)

Franchini M, Franchi M, Bergamini V, Montagnana M, Salvagno GL, Targher G, Lippi G.

Fonte‎: Clin Obstet Gynecol 2010;53(1):219-27.

Indexado‎: PubMed 20142658

DOI‎: 10.1097/GRF.0b013e3181cc4378

https://www.ncbi.nlm.nih.gov/pubmed/20142658 (abre uma nova janela)

Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study. (abre uma nova janela)

Huber AW, Raio L, Alberio L, Ghezzi F, Surbek DV.

Fonte‎: J Perinat Med 2011;40(1):43-9.

Indexado‎: PubMed 22017328

DOI‎: 10.1515/JPM.2011.109

https://www.ncbi.nlm.nih.gov/pubmed/22017328 (abre uma nova janela)

Postpartum hemorrhage: when uterotonics and sutures fail. (abre uma nova janela)

James AH, McLintock C, Lockhart E.

Fonte‎: Am J Hematol 2012;87 Suppl 1:S16-22.

Indexado‎: PubMed 22430921

DOI‎: 10.1002/ajh.23156

https://www.ncbi.nlm.nih.gov/pubmed/22430921 (abre uma nova janela)

Recombinant activated factor VII (rFVIIa/NovoSeven®) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan. (abre uma nova janela)

Kobayashi T, Nakabayashi M, Yoshioka A, Maeda M, Ikenoue T.

Fonte‎: Int J Hematol 2012;95(1):57-63.

Indexado‎: PubMed 22160834

DOI‎: 10.1007/s12185-011-0974-9

https://www.ncbi.nlm.nih.gov/pubmed/22160834 (abre uma nova janela)

Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. (abre uma nova janela)

Lavigne-Lissalde G, Aya AG, Mercier FJ, Roger-Christoph S, Chauleur C, Morau E, Ducloy-Bouthors AS, Mignon A, Raucoules M, Bongain A, Boehlen F, de Moerloose P, Bouvet S, Fabbro-Peray P, Gris JC.

Fonte‎: J Thromb Haemost 2015;13(4):520-9.

Indexado‎: PubMed 25594352

DOI‎: 10.1111/jth.12844

https://www.ncbi.nlm.nih.gov/pubmed/25594352 (abre uma nova janela)

Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy. (abre uma nova janela)

Lim Y, Loo CC, Chia V, Fun W.

Fonte‎: Int J Gynaecol Obstet 2004;87(2):178-9.

Indexado‎: PubMed 15491576

DOI‎: 10.1016/j.ijgo.2004.08.007

https://www.ncbi.nlm.nih.gov/pubmed/15491576 (abre uma nova janela)

Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. (abre uma nova janela)

Moscardó F, Pérez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, Aznar I, Carceller S, Sanz MA.

Fonte‎: Br J Haematol 2001;114(1):174-6.

Indexado‎: PubMed 11472364

https://www.ncbi.nlm.nih.gov/pubmed/11472364 (abre uma nova janela)

Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage. (abre uma nova janela)

Nohira T, Osakabe Y, Suda S, Takahashi C, Tanaka A, Ikeda K, Ikeda T, Okabe K.

Fonte‎: J Obstet Gynaecol Res 2008;34(4 Pt 2):623-30.

Indexado‎: PubMed 18840167

https://www.ncbi.nlm.nih.gov/pubmed/18840167 (abre uma nova janela)

Recombinant factor VIIa as last-resort treatment of desperate haemorrhage. (abre uma nova janela)

Palmason R, Vidarsson B, Sigvaldason K, Ingimarsson JP, Gudbjartsson T, Sigurdsson GH, Onundarson PT.

Fonte‎: Acta Anaesthesiol Scand 2012;56(5):636-44.

Indexado‎: PubMed 22489992

DOI‎: 10.1111/j.1399-6576.2012.02688.x

https://www.ncbi.nlm.nih.gov/pubmed/22489992 (abre uma nova janela)

Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation. (abre uma nova janela)

Pepas LP, Arif-Adib M, Kadir RA.

Fonte‎: Obstet Gynecol 2006;108(3 Pt 2):757-61.

Indexado‎: PubMed 17018493

DOI‎: 10.1097/01.AOG.0000197064.44340.d4

https://www.ncbi.nlm.nih.gov/pubmed/17018493 (abre uma nova janela)

Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. (abre uma nova janela)

Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, Cameron PA; Australian and New Zealand Haemostasis Registry.

Fonte‎: Anesth Analg 2009;109(6):1908-15.

Indexado‎: PubMed 19923520

DOI‎: 10.1213/ANE.0b013e3181c039e6

https://www.ncbi.nlm.nih.gov/pubmed/19923520 (abre uma nova janela)

Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism. (abre uma nova janela)

Prosper SC, Goudge CS, Lupo VR.

Fonte‎: Obstet Gynecol 2007;109(2 Pt2):524-5.

Indexado‎: PubMed 17267882

DOI‎: 10.1097/01.AOG.0000235711.11817.8c

https://www.ncbi.nlm.nih.gov/pubmed/17267882 (abre uma nova janela)

The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage--an observational study. (abre uma nova janela)

Ahmed S, Harrity C, Johnson S, Varadkar S, McMorrow S, Fanning R, Flynn CM, O'Riordan JM, Byrne BM.

Fonte‎: Transfus Med 2012;22(5):344-9.

Indexado‎: PubMed 22994449

https://www.ncbi.nlm.nih.gov/pubmed/22994449 (abre uma nova janela)

The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. (abre uma nova janela)

Bell SF, Rayment R, Collins PW, Collis RE.

Fonte‎: Int J Obstet Anesth 2010;19(2):218-23.

Indexado‎: PubMed 20194010

DOI‎: 10.1016/j.ijoa.2009.08.004

https://www.ncbi.nlm.nih.gov/pubmed/20194010 (abre uma nova janela)

Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. (abre uma nova janela)

Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH, Huissoud C.

Fonte‎: Br J Anaesth 2012;108(6):984-9.

Indexado‎: PubMed 22490316

DOI‎: 10.1093/bja/aes096

https://www.ncbi.nlm.nih.gov/pubmed/22490316 (abre uma nova janela)

Association between fibrinogen levels and severity of postpartum hemorrhage in singleton vaginal deliveries at a Japanese perinatal center. (abre uma nova janela)

Shibata Y, Shigemi D, Ito M, Terada K, Nakanishi K, Kato M, Igarashi M, Suzuki S.

Fonte‎: J Nippon Med Sch 2014;81(2):94-6.

Indexado‎: PubMed 24805095

https://www.ncbi.nlm.nih.gov/pubmed/24805095 (abre uma nova janela)

A systematic review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. (abre uma nova janela)

Trigg DE, Stergiotou I, Peitsidis P, Kadir RA.

Fonte‎: Haemophilia 2012;18(1):25-33.

Indexado‎: PubMed 21624012

DOI‎: 10.1111/j.1365-2516.2011.02573.x

https://www.ncbi.nlm.nih.gov/pubmed/21624012 (abre uma nova janela)

Tisseel for management of traumatic postpartum haemorrhage. (abre uma nova janela)

Dhulkotia JS, Alazzam M, Galimberti A.

Fonte‎: Arch Gynecol Obstet 2009;279(3):437-9.

Indexado‎: PubMed 18985368

DOI‎: 10.1007/s00404-008-0824-z

https://www.ncbi.nlm.nih.gov/pubmed/18985368 (abre uma nova janela)

Use of FloSeal haemostatic gel in massive obstetric haemorrhage: a case report. (abre uma nova janela)

Moriarty KT, Premila S, Bulmer PJ.

Fonte‎: BJOG 2008;115(6):793-5.

Indexado‎: PubMed 18355369

DOI‎: 10.1111/j.1471-0528.2007.01654.x

https://www.ncbi.nlm.nih.gov/pubmed/18355369 (abre uma nova janela)

Topical application of recombinant activated factor VII during cesarean delivery for placenta previa. (abre uma nova janela)

Schjoldager BTBG, Mikkelsen E, Lykke MR, Præst J, Hvas AM, Heslet L, Secher NJ, Salvig JD, Uldbjerg N

Fonte‎: Am J Obstet Gynecol 2017;216(6):608.e1-5.

Indexado‎: PubMed 28219621

DOI‎: 10.1016/j.ajog.2017.02.024

https://www.ncbi.nlm.nih.gov/pubmed/28219621 (abre uma nova janela)

Fibrin sealant for management of complicated obstetric lacerations. (abre uma nova janela)

Whiteside JL, Asif RB, Novello RJ.

Fonte‎: Obstet Gynecol 2010;115(2 Pt 2):403-4.

Indexado‎: PubMed 20093858

DOI‎: 10.1097/AOG.0b013e3181bb1e28

https://www.ncbi.nlm.nih.gov/pubmed/20093858 (abre uma nova janela)

Role of thromboelastography versus coagulation screen as a safety predictor in pre-eclampsia/eclampsia patients undergoing lower-segment caesarean section in regional anaesthesia. (abre uma nova janela)

Ahmad A, Kohli M, Malik A, Kohli M, Bogra J, Abbas H, Gupta R, Kushwaha BB.

Fonte‎: J Obstet Gynaecol India 2016;66(Suppl 1):340-6.

Indexado‎: PubMed 27651627

https://www.ncbi.nlm.nih.gov/pubmed/27651627 (abre uma nova janela)

Assessment of coagulation in the obstetric population using ROTEM® thromboelastometry. (abre uma nova janela)

Armstrong S, Fernando R, Ashpole K, Simons R, Columb M.

Fonte‎: Int J Obstet Anesth 2011;20(4):293-8.

Indexado‎: PubMed 21835606

https://www.ncbi.nlm.nih.gov/pubmed/21835606 (abre uma nova janela)

Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. (abre uma nova janela)

de Lange NM, Lancé MD, de Groot R, Beckers EA, Henskens YM, Scheepers HC.

Fonte‎: Obstet Gynecol Surv 2012;67(7):426-35.

Indexado‎: PubMed 22926249

DOI‎: 10.1097/OGX.0b013e3182605861

https://www.ncbi.nlm.nih.gov/pubmed/22926249 (abre uma nova janela)

Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both? (abre uma nova janela)

Karlsson O, Jeppsson A, Hellgren M.

Fonte‎: Int J Obstet Anesth 2014;23(1):10-7.

Indexado‎: PubMed 24342222

https://www.ncbi.nlm.nih.gov/pubmed/24342222 (abre uma nova janela)

Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. (abre uma nova janela)

Levy JH, Welsby I, Goodnough LT.

Fonte‎: Transfusion 2014;54(5):1389-405.

Indexado‎: PubMed 24117955

DOI‎: 10.1111/trf.12431

https://www.ncbi.nlm.nih.gov/pubmed/24117955 (abre uma nova janela)

Coagulopathy and placental abruption: changing management with ROTEM-guided fibrinogen concentrate therapy. (abre uma nova janela)

McNamara H, Mallaiah S, Barclay P, Chevannes C, Bhalla A.

Fonte‎: Int J Obstet Anesth 2015;24(2):174-9.

Indexado‎: PubMed 25659517

https://www.ncbi.nlm.nih.gov/pubmed/25659517 (abre uma nova janela)

Haemostatic monitoring during postpartum haemorrhage and implications for management. (abre uma nova janela)

Solomon C, Collis RE, Collins PW.

Fonte‎: Br J Anaesth 2012;109(6):851-63.

Indexado‎: PubMed 23075633

DOI‎: 10.1093/bja/aes361

https://www.ncbi.nlm.nih.gov/pubmed/23075633 (abre uma nova janela)